ARTICLES BY THIS AUTHOR

• 8/22/2017

  Toronto psychiatrist loses licence over relationship with former patient

• 8/22/2017

  $2M donation supports palliative program at Vancouver Coastal

• 8/22/2017

  Discovery of genetic mutation could help target treatment for prostate cancer

• 8/22/2017

  What’s new in insulin therapy?

• 8/22/2017

  Peanut allergy cured in the majority of children, study shows

  Given that peanut allergy is the most common cause of anaphylaxis and death from food allergy, Australian researchers are pioneering a new form of treatment to cure it.
• 8/22/2017

  HealthCareCAN partnership will help improve access to health programs

• 8/22/2017

  Quebec health minister raises question of reopening Canada Health Act

• 8/22/2017

  Abortion barrier likely 'historical practice,' not law: N.S. health minister

• 8/22/2017

  Scott Livingstone named CEO for new Saskatchewan health authority superboard

• 8/21/2017

  Health Canada approves two new drug combos for chronic hepatitis C

  Vosevi, a single-tablet 12-week regimen for retreatment, and Maviret, an 8-week pan-genotypic treatment for noncirrhotic treatment-naïve patients